ACS Medicinal Chemistry Letters p. 277 - 282 (2016)
Update date:2022-07-30
Topics:
Focken, Thilo
Liu, Shifeng
Chahal, Navjot
Dauphinais, Maxim
Grimwood, Michael E.
Chowdhury, Sultan
Hemeon, Ivan
Bichler, Paul
Bogucki, David
Waldbrook, Matthew
Bankar, Girish
Sojo, Luis E.
Young, Clint
Lin, Sophia
Shuart, Noah
Kwan, Rainbow
Pang, Jodie
Chang, Jae H.
Safina, Brian S.
Sutherlin, Daniel P.
Johnson
Dehnhardt, Christoph M.
Mansour, Tarek S.
Oballa, Renata M.
Cohen, Charles J.
Robinette, C. Lee
We report on a novel series of aryl sulfonamides that act as nanomolar potent, isoform-selective inhibitors of the human sodium channel hNaV1.7. The optimization of these inhibitors is described. We aimed to improve potency against hNaV1.7 while minimizing off-target safety concerns and generated compound 3. This agent displayed significant analgesic effects in rodent models of acute and inflammatory pain and demonstrated that binding to the voltage sensor domain 4 site of NaV1.7 leads to an analgesic effect in vivo. Our findings corroborate the importance of hNaV1.7 as a drug target for the treatment of pain.
View MoreContact:+86-21-54391580
Address:Room 502,No.65,Lane 2388 Hongxin Road,Shanghai,China
website:http://www.apeptides.com/en/
Contact:+86-21-60871011
Address:No. 80 Chuanshan Shuyuan Steet,Pudong,Shanghai
Anhui Biochem United Pharmaceutical Co., Ltd.
Contact:0086 551 5167062 / 5228268
Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
Henan PURUI Pharmaceutical Co., Ltd.
website:http://www.puruipharm.com
Contact:17739583555
Address:Yezhuangqiao,Xihua town, Henan province
Wuxi Zuping Food Science And Technology Co.,LTD.
Contact:+86-510-87210822
Address:Guanlin town
Doi:10.1039/c3dt32860k
(2013)Doi:10.1002/ardp.19923250713
(1992)Doi:10.1039/c3dt32939a
(2013)Doi:10.1071/CH08414
(2009)Doi:10.1002/anie.201206438
(2012)Doi:10.1021/jacs.9b12214
(2020)